Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

9.70
Delayed Data
As of Jan 18
 +0.05 / +0.52%
Today’s Change
7.33
Today|||52-Week Range
13.70
-20.16%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close9.65
Today’s open9.75
Day’s range9.40 - 10.05
Volume488,979
Average volume (3 months)221,797
Market cap$239.2M
Dividend yield--
Data as of 4:00pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-578.65%
Earnings growth (this year)-318.58%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-31.70%
P/E ratioNM
Price/Sales11.42
Price/Book1.31

Competitors

 Today’s
change
Today’s
% change
STMLStemline Therapeutic...-0.40-3.31%
TGTXTG Therapeutics Inc-0.05-1.09%
ESPREsperion Therapeutic...+0.07+0.63%
IDRAIdera Pharmaceutical...-0.03-1.99%
Data as of 4:00pm ET, 01/18/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$27.7M
Annual profit (last year)-$49.3M
Net profit margin-150.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Michael P. Smith
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs